成分分析

UFLC-MS/MS法同时测定黄芪建中汤中6个活性成分的含量*

展开
  • 吉林医药学院 药学院,吉林 132013
第一作者 Tel:(0432)64560528; E-mail:rainbowguanjiao@sina.com
**崔 悦 Tel:(0432)64560530; E-mail:cuiyuecy002@163.com
朱鹤云 Tel:(0432) 64561064; E-mail:zhy19820903@126.com

收稿日期: 2021-05-26

  网络出版日期: 2024-06-21

基金资助

*国家自然科学基金项目(81703683);吉林省科技厅项目(YDZJ202101ZYTS074);吉林省教育厅课题(JJKH20210492KJ;JJKH20191071KJ);吉林省中医药管理局项目(2021168;2021169);吉林省大学生创新创业训练计划项目(S202113706075;202013706016)

Simultaneous determination of six active components in Huangqi Jianzhong decoction by UFLC-MS/MS*

Expand
  • School of Pharmacy, Jilin Medical University, Jilin 132013, China

Received date: 2021-05-26

  Online published: 2024-06-21

摘要

目的:建立一种同时测定黄芪建中汤中6个活性成分(毛蕊异黄酮-7-O-β-D-吡喃葡萄糖苷、桂皮酸、芍药苷、芍药内酯苷、甘草苷和甘草酸)含量的超快速液相色谱-串联质谱法。方法:采用Shim-Pack XR-ODS色谱柱(75 mm×3.0 mm, 2.2 μm),以0.1%甲酸水溶液(A)-乙腈(B)为流动相,梯度洗脱(0~6.0 min,12%B→25%B;6.0~7.0 min,25%B→45%B;7.0~11.0 min,45%B→60%B;11.0~13.0 min,60%B→70%B),平衡时间5 min,流速0.4 mL·min-1,柱温30 ℃,进样量5 μL;采用电喷雾电离源(ESI源),负离子模式检测,多反应监测(MRM)。结果:毛蕊异黄酮-7-O-β-D-吡喃葡萄糖苷、桂皮酸、芍药苷、芍药内酯苷、甘草苷和甘草酸质量浓度分别在0.2~10 μg·mL-1(r=0.999 6)、0.5~25 μg·mL-1(r=0.999 5)、2~100 μg·mL-1(r=0.999 6)、0.5~25 μg·mL-1(r=0.999 8)、0.5~25 μg·mL-1(r=0.999 7)和0.5~25 μg·mL-1(r=0.999 6)范围内与峰面积呈良好线性关系;平均回收率(n=9)分别为98.3%、98.4%、98.9%、98.0%、98.8%和99.2%。6批样品中上述6个成分的含量分别为0.114~0.128、0.118~0.144、4.19~4.52、1.03~1.12、0.277~0.345、0.679~0.798 mg·mL-1结论:本方法灵敏度高,稳定性好,可用于黄芪建中汤的质量控制。

本文引用格式

关皎, 王悦, 廖宇, 高兴, 周新新, 冯波, 崔悦, 朱鹤云 . UFLC-MS/MS法同时测定黄芪建中汤中6个活性成分的含量*[J]. 药物分析杂志, 2022 , 42(1) : 133 -139 . DOI: 10.16155/j.0254-1793.2022.01.15

Abstract

Objective: To establish an ultra-fast liquid chromatography with tandem mass spectrometry (UFLC-MS/MS) method for simultaneous determination of six active components (calycosin-7-O-β-D-glucopyranoside, cinnamic acid, paeoniflorin, albiflorin, liquiritin and glycyrrhizic acid) in Huangqi Jianzhong decoction Methods: Chromatographic separation was performed on a Shim-Pack XR-ODS column (75 mm×3.0 mm, 2.2 μm). The mobile phase consisted of 0.1% formic acid in water (A) and acetonitrile (B) at a flow rate of 0.4 mL·mL-1. The six analytes were determined with gradient elution (0-6 min, 12%B→25%B; 6-7 min, 25%B→45%B; 7-11 min, 45%B→60%B; 11-13 min, 60%B→70%B), and the equilibration time was 5 min. The column temperature was maintained at 30 ℃, and the injection volume was 5 μL. Detection was performed with electrospray ionization source in negative ionization mode. Quantification was performed using multiple reactions monitoring (MRM) mode. Results: The linear ranges of calycosin-7-O-β-D-glucopyranoside, cinnamic acid, paeoniflorin, albiflorin, liquiritin and glycyrrhizic acid were 0.2-10 μg·mL-1 (r=0.999 6), 0.5-25 μg·mL-1 (r=0.999 5), 2-100 μg·mL-1 (r=0.999 6), 0.5-25 μg·mL-1 (r=0.999 8), 0.5-25 μg·mL-1 (r=0.999 7) and 0.5-25 μg·mL-1 (r=0.999 6), respectively. The average recoveries (n=9) of the above-mentioned six components were 98.3%, 98.4%, 98.9%, 98.0%, 98.8% and 99.2%, respectively. The content ranges of six components in six batches were 0.114-0.128 mg·mL-1 for calycosin-7-O-β-D-glucopyranoside, 0.118-0.144 mg·mL-1 for cinnamic acid, 4.19-4.52 mg·mL-1 for paeoniflorin, 1.03-1.12 mg·mL-1 for albiflorin, 0.277-0.345 mg·mL-1 for liquiritin and 0.679-0.798 mg·mL-1 for glycyrrhizic acid. Conclusion: The established method is accurate, stable and reproducible,and can provide a research method for the quality control of Huangqi Jianzhong decoction.

参考文献

[1] 张云, 龚航军, 韩刚, 等. 黄芪建中汤加速腹腔镜远端胃癌手术患者康复的临床疗效观察[J].中国中医药科技, 2020, 27(2):247
ZHANG Y, GONG HJ, HAN G, et al. Clinical observation of Huangqi Jianzhong decoction in accelerating the rehabilitation of patients with laparoscopic distal gastric cancer surgery[J].Chin J Tradit Med Sci Technol, 2020, 27(2):247
[2] 陈建细, 李俊, 赵娜, 等. 黄芪建中汤在消化系统中的临床应用进展[J].实用中西医结合临床, 2017, 17(8):162
CHEN JX, LI J, ZHAO N, et al. Clinical application progress of Huangqi Jianzhong decoction in digestive system[J].Pract Clin J Integr Tradit Chin West Med, 2017, 17(8):162
[3] 朱巧凤, 韩吉. 黄芪建中汤治疗胃病临床及实验研究进展[J].亚太传统医药, 2019, 15(10):179
ZHU QF, HAN J. Clinical and experimental research progress of Huangqi Jianzhong decoction in treating stomach disease[J].Asia Pac Tradit Med, 2019, 15(10):179
[4] 许文倩, 秦雪梅, 刘月涛. 基于网络药理学的黄芪建中汤治疗慢性萎缩性胃炎作用机制研究[J].中草药, 2018, 49(15):3550
XU WQ, QIN XM, LIU YT. Mechanism of Huangqi Jianzhong decoction in treating chronic atrophic gastritis based on network pharmacology[J].Chin Tradit Herb Drugs, 2018, 49(15):3550
[5] 闫芳. 黄芪建中汤治疗脾胃虚寒型胃溃疡60例[J].河南中医, 2020, 40(10):1503
YAN F. Sixty cases of gastric ulcer with spleen and stomach deficiency cold syndrome treated with Astragalus center-fortifying decoction[J].Henan Tradit Chin Med, 2020, 40(10):1503
[6] 王晓芳, 于丹, 刘春英. 黄芪建中汤含药血清联合顺铂对人肺癌A549细胞增殖及E-cadherin、Snail1表达的影响[J].中国当代医药, 2020, 27(10):4
WANG XF, YU D, LIU CY. Effect of serum containing Huangqi Jianzhong decoction combined with cisplatin on A549 cell proliferation and expression of E-cadherin and Snail1 in human lung cancer[J].Chin Mod Med, 2020, 27(10):4
[7] 胡妮娜, 张晓娟. 黄芪的化学成分及药理作用研究进展[J].中医药信息, 2021, 38(1):76
HU NN, ZHANG XJ. Research progress on chemical constituents and pharmacological effects of Astragalus membranaceus[J].Inf Tradit Chin Med, 2021, 38(1):76
[8] PAN H, LI X, CHENG X, et al. Evidence of calycosin-7-O-β-D-glucoside's role as a major antioxidant molecule of Astragalus membranaceus Bge. var. mongholicus (Bge.) Hsiao plants under freezing stress[J].Environ Exp Bot, 2015, 109(1):1
[9] ZHANG JQ, XUE XL, YANG Y, et al. Multiple biological defects caused by calycosin-7-O-β-D-glucoside in the nematode Caenorhabditis elegans are associated with the activation of oxidative damage[J].J Appl Toxicol, 2018, 38(6):801
[10] REN M, WANG X, DU G, et al. Calycosin-7-O-β-D-glucoside attenuates ischemia reperfusion injury in vivo via activation of the PI3K/Akt pathway[J].Mol Med Rep, 2016, 13(1):633
[11] 郝霁萍, 高宇勤, 贺少辉, 等. 肉桂酸预处理对大鼠心肌缺血再灌注损伤的影响及机制[J].中国循证心血管医学杂志, 2016, 8(7):800
HAO JP, GAO YQ, HE SH, et al. Protective effect of cinnamic acid preconditioning in the myocardial ischemia reperfusion injury of rats by activating Akt signal pathway[J].Chin J Evid Based Cardiovasc Med, 2016, 8(7):800
[12] 张育贵, 张淑娟, 边甜甜, 等. 芍药苷药理作用研究新进展[J].中草药, 2019, 50(15):3735
ZHANG YG, ZHANG SJ, BIAN TT, et al. New progress in pharmacological action of paeoniflorin[J].Chin Tradit Herb Drugs, 2019, 50(15):3735
[13] 李葆林, 麻景梅, 田宇柔, 等. 甘草中新发现化学成分和药理作用的研究进展[J].中草药, 2021, 52(8):2438
LI BL, MA JM, TIAN YR, et al. Research progress on newly discovered chemical constituents and pharmacological effects of Glycyrrhizae Radix et Rhizoma[J].Chin Tradit Herb Drugs, 2021, 52(8):2438
[14] 张光辉, 郭惠, 张拴, 等. 甘草苷的合成及抗氧化活性研究[J].化学与生物工程, 2019, 36(10):16
ZHANG GH, GUO H, ZHANG S, et al. Synthesis and antioxidant activity of liquiritin[J].Chem Bioeng, 2019, 36(10):16
[15] TENG LS, MENG QF, LU JH, et al. Liquiritin modulates ERK-and AKT/GSK-3β-dependent pathways to protect against glutamate-induced cell damage in differentiated PC12 cells[J].Mol Med Rep, 2014, 10(2):818
[16] 罗敏, 肖婷婷, 曾星, 等. 甘草酸对LPS诱导的IEC-6细胞NF-κB通路及炎症因子表达的影响[J].中国免疫学杂志, 2019, 35(10):1160
LUO M, XIAO TT, ZENG X, et al. Effects of glycyrrhizic acid on LPS-induced activation of IEC-6 cells NF-κB pathway and expression of inflammatory factors[J].Chin J Immunol, 2019, 35(10):1160
文章导航

/